Literature DB >> 29556693

Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.

Tomotaka Ando1, Yoshitaka Okuhara1, Yoshiyuki Orihara1, Koichi Nishimura1, Kyoko Yamamoto1, Tohru Masuyama1, Shinichi Hirotani2.   

Abstract

Recently, we and other group have reported that furosemide administration along with hypertonic saline solution enhanced diuretic efficiency of furosemide. However, little is known about factors which associated with high diuretic efficiency by hypertonic saline solution with furosemide therapy. To identify predictors of diuretic efficiency in the hypertonic saline solution with furosemide therapy, we recruited 30 consecutive hospitalized heart failure (HF) patients with volume overload (77 ± 10 years, systolic blood pressure > 90 mmHg, and estimated glomerular filtration rate > 15 ml/min/1.73 m2). Hypertonic saline with furosemide solution, consisting of 500 ml of 1.7% hypertonic saline solution with 40 mg of furosemide, was administered continuously over 24 h. The patients were divided into two groups on the basis of 24-h urine volume (UV) after initiation of diuretic treatment ≥ 2000 ml (high urine volume: HUV) and < 2000 ml (low urine volume: LUV). The basal clinical characteristics of both groups were analyzed and the predictors of HUV after receiving the treatment were identified. There were not significant differences between two groups in baseline clinical characteristics and medication. Univariate logistic analysis revealed that blood urea nitrogen/creatinine ratio, urine urea nitrogen/creatinine ratio (UUN/UCre), fractional excretion of sodium, and tricuspid annular plane systolic excursion positively associated with HUV. Multivariate logistic regression analysis revealed that UUN/UCre at baseline was independently associated with HUV, and UUN/UCre best predicts HUV by the therapy with a cut-off value of 6.16 g/dl/g Cre (AUC 0.910, 95% CI 0.696-0.999, sensitivity 80%, specificity 87%). The Kaplan-Meier curves revealed significant difference for HF rehospitalization and death rate at 180 days between patients with UUN/UCre ≥ 6.16 g/dl/g Cre and those with UUN/UCre < 6.16 g/dl/g Cre (log-rank P = 0.0489). UUN/UCre at baseline strongly predicted of diuretic efficiency in the hypertonic saline solution with furosemide therapy, and was associated with HF prognosis.

Entities:  

Keywords:  Acute decompensated heart failure; Diuretic efficiency; Hypertonic saline; Loop diuretics

Mesh:

Substances:

Year:  2018        PMID: 29556693     DOI: 10.1007/s00380-018-1156-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  18 in total

Review 1.  Diuretics and ultrafiltration in acute decompensated heart failure.

Authors:  G Michael Felker; Robert J Mentz
Journal:  J Am Coll Cardiol       Date:  2012-06-12       Impact factor: 24.094

Review 2.  Congestion in acute heart failure syndromes: an essential target of evaluation and treatment.

Authors:  Mihai Gheorghiade; Gerasimos Filippatos; Leonardo De Luca; John Burnett
Journal:  Am J Med       Date:  2006-12       Impact factor: 4.965

3.  Relation of loop diuretic dose to mortality in advanced heart failure.

Authors:  Shervin Eshaghian; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2006-04-27       Impact factor: 2.778

4.  Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

Authors:  Giuseppe Licata; Pietro Di Pasquale; Gaspare Parrinello; Antonietta Cardinale; Angela Scandurra; Giuseppe Follone; Christiano Argano; Antonino Tuttolomondo; Salvatore Paterna
Journal:  Am Heart J       Date:  2003-03       Impact factor: 4.749

5.  Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition.

Authors:  M Volpe; P Magri; M A Rao; S Cangianiello; L DeNicola; A F Mele; B Memoli; I Enea; S Rubattu; B Gigante; B Trimarco; M Epstein; M Condorelli
Journal:  Hypertension       Date:  1997-08       Impact factor: 10.190

6.  Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.

Authors:  Victor Sarli Issa; Fernando Bacal; Sandrigo Mangini; Rodrigo Moreno Dias Carneiro; Cristiano Humberto Naves de Freitas Azevedo; Paulo Roberto Chizzola; Silvia Moreira Ayub Ferreira; Edimar Alcides Bocchi
Journal:  Arq Bras Cardiol       Date:  2007-10       Impact factor: 2.000

7.  Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.

Authors:  Yoshitaka Okuhara; Shinichi Hirotani; Yoshiro Naito; Ayumi Nakabo; Toshihiro Iwasaku; Akiyo Eguchi; Daisuke Morisawa; Tomotaka Ando; Hisashi Sawada; Eri Manabe; Tohru Masuyama
Journal:  J Card Fail       Date:  2014-01-22       Impact factor: 5.712

Review 8.  Pathogenesis of sodium and water retention in cardiac failure.

Authors:  R W Schrier; R G Fassett
Journal:  Ren Fail       Date:  1998-11       Impact factor: 2.606

9.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

10.  Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.

Authors:  Dhssraj Singh; Kevin Shrestha; Jeffrey M Testani; Frederik H Verbrugge; Matthias Dupont; Wilfried Mullens; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-04-02       Impact factor: 5.712

View more
  2 in total

Review 1.  The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines.

Authors:  Matteo Beltrami; Massimo Milli; Lorenzo Lupo Dei; Alberto Palazzuoli
Journal:  J Clin Med       Date:  2022-04-17       Impact factor: 4.964

Review 2.  Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review.

Authors:  Simge Acar; Sueda Sanli; Cinar Oztosun; Baris Afsar; Alan A Sag; Masanari Kuwabara; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.